Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Enterprise Value (2016 - 2025)

Pediatrix Medical (MD) has disclosed Enterprise Value for 17 consecutive years, with -$499.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 43.39% to -$499.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$499.7 million, a 43.39% decrease, with the full-year FY2025 number at -$499.7 million, down 43.39% from a year prior.
  • Enterprise Value was -$499.7 million for Q4 2025 at Pediatrix Medical, down from -$463.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$96.8 million in Q1 2022 to a low of -$499.7 million in Q4 2025.
  • A 5-year average of -$250.8 million and a median of -$198.5 million in 2023 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: skyrocketed 78.83% in 2022, then plummeted 161.51% in 2025.
  • Pediatrix Medical's Enterprise Value stood at -$486.9 million in 2021, then surged by 78.83% to -$103.1 million in 2022, then crashed by 72.46% to -$177.7 million in 2023, then tumbled by 96.07% to -$348.5 million in 2024, then plummeted by 43.39% to -$499.7 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Enterprise Value are -$499.7 million (Q4 2025), -$463.1 million (Q3 2025), and -$348.3 million (Q2 2025).